BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21106240)

  • 21. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
    Shutoh M; Oue N; Aung PP; Noguchi T; Kuraoka K; Nakayama H; Kawahara K; Yasui W
    Cancer; 2005 Oct; 104(8):1609-19. PubMed ID: 16134180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aberrant DNA methylation in thymic epithelial tumors.
    Chen C; Yin B; Wei Q; Li D; Hu J; Yu F; Lu Q
    Cancer Invest; 2009 Jun; 27(5):582-91. PubMed ID: 19340654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Methylation and expression of glioma pathogenesis-related protein 1 gene in acute myeloid leukemia].
    Liang T; Tan T; Xiao Y; Yi H; Li C; Peng F; Chen Z; Xiao Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 May; 34(5):388-94. PubMed ID: 19483285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
    Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemia.
    Suzuki R; Onizuka M; Kojima M; Shimada M; Fukagawa S; Tsuboi K; Kobayashi H; Shintani A; Ogawa Y; Kawada H; Hotta T; Ando K
    Br J Haematol; 2007 Sep; 138(5):624-31. PubMed ID: 17686056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic variation at the MDR1 promoter and P-glycoprotein expression and activity in AML patients.
    Lourenço JJ; Maia RC; Scheiner MA; Vasconcelos FC; Moreira MA
    Leuk Res; 2008 Jun; 32(6):976-9. PubMed ID: 18001833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.
    Zhang W; Zhou L; Ding SM; Xie HY; Xu X; Wu J; Chen QX; Zhang F; Wei BJ; Eldin AT; Zheng SS
    Oncol Rep; 2011 Apr; 25(4):1053-62. PubMed ID: 21271221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia.
    Shimamoto T; Ohyashiki JH; Ohyashiki K
    Leuk Res; 2005 Jun; 29(6):653-9. PubMed ID: 15863205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia.
    Lin TC; Hou HA; Chou WC; Ou DL; Yu SL; Tien HF; Lin LI
    Leukemia; 2011 Jan; 25(1):32-40. PubMed ID: 20927134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.
    Wang H; Wang XQ; Xu XP; Lin GW
    Leuk Res; 2010 May; 34(5):598-604. PubMed ID: 19853913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.
    Aggerholm A; Holm MS; Guldberg P; Olesen LH; Hokland P
    Eur J Haematol; 2006 Jan; 76(1):23-32. PubMed ID: 16343268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
    Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis.
    Fasan A; Eder C; Haferlach C; Grossmann V; Kohlmann A; Dicker F; Kern W; Haferlach T; Schnittger S
    Leukemia; 2013 Feb; 27(2):482-5. PubMed ID: 22814295
    [No Abstract]   [Full Text] [Related]  

  • 35. [Alteration of methylation status of death-associated protein kinase (dapk) gene promoter in patients with acute myeloid leukemia].
    Qian J; Yao DM; Lin J; Chen Q; Li Y; Ji RB; Yang J; Qian Z; Xiao GF; Wang YL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1390-4. PubMed ID: 21176336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
    Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia.
    Niu J; Li H; Zhang Y; Li J; Xie M; Li L; Qin X; Qin Y; Guo X; Jiang Q; Liu Y; Chen S; Huang X; Han W; Ruan G
    Leuk Res; 2011 Jun; 35(6):771-6. PubMed ID: 21168207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element.
    Bonadies N; Neururer Ch; Steege A; Vallabhapurapu S; Pabst T; Mueller BU
    Oncogene; 2010 Feb; 29(7):1062-72. PubMed ID: 19966852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation status of DDIT3 gene in chronic myeloid leukemia.
    Wang YL; Qian J; Lin J; Yao DM; Qian Z; Zhu ZH; Li JY
    J Exp Clin Cancer Res; 2010 May; 29(1):54. PubMed ID: 20492726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
    Pabst T; Eyholzer M; Haefliger S; Schardt J; Mueller BU
    J Clin Oncol; 2008 Nov; 26(31):5088-93. PubMed ID: 18768433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.